Exactus, Inc. (EXDI) - New Audited Fully Reporting Cannabis Company Under $2.00 That Could See Over $10 Soon
New York, NY -- April 11, 2019 -- InvestorsHub NewsWire -- www.nextbigticker.com -- Exactus, Inc. (OTCQB: EXDI) is a new audited and fully reporting cannabis sector company that has targeted the very lucrative CBD market with a 200-acer hemp farm as its first asset and a $1 million CBD order on the books. EXDI has set out to make itself a leading brand name recognized for top quality CBD. With industry estimates ranging from $30,000 to $60,000 in CBD revenue per acre, EXDI could realize $6 million to $12 million in sales this year. Some analysts have estimated CBD revenue per acer even higher than the $30,000 to $60,000 range.
Aurora Cannabis (NYSE: ACB) CCO Cam Battley refers to cannabis stock valuation potentials in hockey stick terms where early stage valuations are on the blade, turning through an inflection point and then rocketing up the stick. Even with audited and fully reporting cannabis sector companies trading at 100 x P/E ratios, valuations today are characterized in hockey stick terms as still being in the blade or inflection point stages.
EXDI is yet undiscovered by the market with relatively light trading volume and a recent PPS ranging from $1.25 to $1.85. EXDI’s valuation in hockey stick terms is still a blade opportunity. The EXDI valuation will enter the inflection stage this year as it signs more orders in addition to its first $1 million order for CBD to be produced from its 200-acre hemp farm. As more orders come in validating EXDI’s $6 million to $12 million first year revenue potential, the market is likely to discover EXDI bringing liquidity and stabilizing PPS volatility.
The legalization of recreational marijuana in Canada has ushered Canadian Cannabis Sector Companies into the hockey stick inflection stage of growth. US Cannabis Sector Companies focused on the CBD sector will begin entering the inflection stage his year as US States begin to adopt the 2018 Farm Act legalization of hemp farming.
EXDI $2.00 to $10.00 PPS Potential
With the high margin potential of CBD production from hemp farming and the cannabis sector inflection point P/E ratios currently accepted by the market, EXDI has the potential to see a substantial PPS increase this year. If EXDI can demonstrate the potential for producing a $3 million net income by signing additional CBD orders and demonstrating reasonable yield management evidenced in its quarterly reports, the PPS has the potential to reach $5.00 if it only modestly enjoys the current cannabis sector P/E ratios seen in the market today. A more optimistic, but still relatively conservative realization of prevailing cannabis sector valuations could see EXDI reach a $10.00 PPS by year end.
EXDI has an experienced and proven management team that brings both cannabis sector experience and a broad and deep range of experience in health sciences - which should provide a good idea about the direction the management team plans to take their CBD product. The CEO, Philip Young has served as President, Chief Executive Officer and Director for AmpliPhi Biosciences, a global biopharmaceutical company. Before that, he was the President, CEO and Director of Osteologix, Inc. Prior to joining Osteologix, Mr. Young served as an Executive Vice President and Chief Business Officer for Insmed Inc., a publicly traded biotechnology company. Prior to Insmed Inc., Mr. Young held executive positions at Elan, Neurex, and Pharmacia Corporations. Mr. Young started his management career in the biopharmaceutical industry at Genentech Inc. where he was responsible for their cardiovascular and endocrine product launches sales and marketing.
EXDI Berkshire Hathaway ROI Potential
With Mr. Young’s experience and the experience of the rest of the executive team, EXDI has the look of being a serious US Cannabis Sector contender. An investment in EXDI stock under $2.00 could produce an exciting cannabis sector ROI of over 100% and perhaps as high as 500% this year if the company performs on what is publicly disclosed and realizes a PPS of $5.00 to $10.00. With the caliber of the management team that has come together at EXDI and the investment that has been made in building the company as an audited and fully reporting company, it is fair to speculate that the company probably has bigger plans that have not yet been disclosed – perhaps a up-listing to NASDAQ and some substantial M&A activity is in the works. With the inclusion of possibly yet unknown aspects of the business plan in the works, an EXDI investment today under $2.00 could produce Berkshire Hathaway returns.
Learn more about EXDI at https://www.exactusinc.com/
A robust cannabis sector investment portfolio should include a combination of fast-moving penny and sub penny priced stocks that can produce multiples in days or weeks when a company signs a new contract, or transacts some other major milestone. That robust cannabis sector investment portfolio also needs to include one or two diligent, longer-term reaching companies like EXDI that could produce life changing wealth. Look for fast returns from companies such as Puration, Inc. (USOTC: PURA), North American Cannabis Holdings, Inc. (USOTC: USMJ) and Hemp, Inc. (USOTC: HEMP) and then add an EXDI to your portfolio.
DISCLAIMER: NextBigTicker.com (NBT)is a third party publisher and news dissemination service provider. NBT is NOT affiliated in any manner with any company mentioned herein. NBT is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. NBT's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. NBT is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. NBT has not been compensated for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.